Pancreatic Cancer Research

ResearcherTongji HospitalActive in the last 2 years

Shunfang Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6267-6482; OpenAlex author ID A5023306981. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. BNC2 as a novel driver of pancreatic cancer progression through transcriptional regulation of COL3A1 and epithelial-to-mesenchymal transition. Co-author DOI 10.1007/s12032-025-03139-9↗
  2. Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2. Last author DOI 10.1177/1010428317698364↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiuming Li · 1 shared paper, 2025 · strength 0.26
  2. Bin Liu · 1 shared paper, 2025 · strength 0.26
  3. Dan Wang · 1 shared paper, 2025 · strength 0.26
  4. Guopeng Zhang · 1 shared paper, 2017 · strength 0.07
  5. Guangyuan Hu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.